C4 Therapeutics, Inc. (CCCC)
2.43
-0.04
(-1.62%)
USD |
NASDAQ |
Dec 15, 16:00
2.45
+0.02
(+0.82%)
After-Hours: 20:00
C4 Therapeutics EPS Diluted (Quarterly): -0.4433 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Biogen, Inc. | 3.171 |
| Amicus Therapeutics, Inc. | 0.0558 |
| GT Biopharma, Inc. | -0.8268 |
| Nurix Therapeutics, Inc. | -1.027 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.17M |
| Revenue (Quarterly) | 11.23M |
| Total Expenses (Quarterly) | 43.40M |
| Enterprise Value | 105.08M |
| Gross Profit Margin (Quarterly) | 81.55% |
| Profit Margin (Quarterly) | -286.4% |
| Earnings Yield | -68.77% |
| Normalized Earnings Yield | -64.50 |